Monoclonal antibody targeting HBsAg(Yangsheng Tang)
N/A
Report date: 2024/07/17 20:00:53
Base Information
Drug NameMonoclonal antibody targeting HBsAg(Yangsheng Tang)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYangsheng Tang Co Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A